GLP-1 TV · Clinician
Ozempic vs Wegovy vs Mounjaro. Which one ACTUALLY gives the most weight loss?
Today’s cheapest GLP-1$39/mo at Wellmedr, sale price.Compare all GLP-1 prices Price read 22 Nov 2026 from the seller’s own page, ranked by price alone. That price is a compounded drug, and compounded drugs are not FDA-approved. Not from the video’s creator.Our summary
In this video, the channel compares Ozempic, Wegovy and Mounjaro to see which one gives the most weight loss. He explains that all three are GLP-1 agonists, which mimic a hormone that prompts the pancreas to release insulin. He says they were first used for diabetes and are now also used for weight loss because they reduce appetite. Ozempic and Wegovy share the active ingredient semaglutide, with Ozempic available at 0.5 to 2 mg and Wegovy only at 2.4 mg. Mounjaro contains tirzepatide, which he describes as acting on both GLP-1 and GIP.
Published by Dr Kidd on YouTube
As published by the channel. Not medical advice, and not an endorsement.
What else the video covers
He then goes through trial figures. For Ozempic, studies in people with diabetes showed average losses of about 4.23% to 6.4% across doses of 0.5 mg, 1 mg and 2 mg. For Wegovy, he cites 14.9% at 68 weeks and 15.2% at 104 weeks, with weight loss levelling off after about one year. For Mounjaro, he cites 15%, 19.5% and 20.1% at 5 mg, 10 mg and 15 mg after 72 weeks. He also reports a 40-week head-to-head study in diabetes where Mounjaro reached 12.4% at 15 mg against 6.2% for Ozempic 1 mg.
His conclusion is that Mounjaro appears most effective, with peak losses of roughly 6% for Ozempic, 15% for Wegovy and 20% for Mounjaro. He adds caveats: the Ozempic studies were only in people with diabetes, and he found no direct comparison of Mounjaro with Wegovy, so population differences could explain some of the gap. He also notes the 10 mg and 15 mg Mounjaro doses looked similar, which he reads as diminishing returns above 10 mg.
Our summary of what is said, in our words. Doses, results and prices are the speaker’s, not advice.
Takeaways
The main points, in the order they come up. Tap a time to play from there.
- 1:01 The channel says Ozempic and Wegovy both contain semaglutide, while Mounjaro contains tirzepatide, which acts on both GLP-1 and GIP.
- 1:30 He reports Ozempic trials, all in people with diabetes, showing average weight loss between 4.23% and 6.4%.
- 3:37 He cites Wegovy trials with average loss of 14.9% at 68 weeks and 15.2% at 104 weeks, levelling off after about a year.
- 5:07 He reports Mounjaro at 72 weeks averaging 15% (5 mg), 19.5% (10 mg) and 20.1% (15 mg).
- 6:40 In the one head-to-head study he found, Mounjaro 15 mg gave 12.4% loss at 40 weeks versus 6.2% for Ozempic 1 mg.
- 7:41 He concludes Mounjaro looks most effective, but says no direct Wegovy comparison exists and the populations differed.
Key moments
Tap one to play from there.
What the video says
As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.
- Medication
- Ozempic, Wegovy, Mounjaro and semaglutide
Questions this video answers
Which gives more weight loss, Ozempic, Wegovy or Mounjaro?
According to the channel, Mounjaro appears most effective, with a peak loss of about 20%, compared with about 15% for Wegovy and about 6% for Ozempic. He cautions that the studies differed in populations and designs.
Are Ozempic and Wegovy the same drug?
The video says both contain semaglutide. Ozempic comes in 0.5 to 2 mg doses, while Wegovy comes only as 2.4 mg.
Is Mounjaro better than Ozempic for weight loss?
The channel cites a 40-week study in people with diabetes that compared them directly. Mounjaro gave 7.8%, 10.3% and 12.4% at 5, 10 and 15 mg, versus 6.2% for Ozempic 1 mg, which he says suggests Mounjaro is more effective.
Does weight loss keep going after a year on Wegovy or Mounjaro?
He says weight loss on Wegovy was fairly steady up to about one year and then plateaued, with weight staying roughly the same through year two. He says Mounjaro showed a similar levelling out after about a year, though that study did not run long enough to confirm it.
Videos on the same question
The closest videos in the library by what is said in them, not by title.
Mounjaro (Tirzepatide) Vs Ozempic (Semaglutide) For Weight Loss & Diabetes ManagementA pharmacist named the speaker compares Mounjaro (tirzepatide) with Ozempic (semaglutide) for diabetes management and weight loss.- What a GLP-1 costs at every program we trackToday’s lowest is $39/mo. Every program ranked by price alone. Compounded drugs are not FDA-approved.
Wegovy vs Zepbound for Weight Loss! and how they work...The speaker, who describes herself as a board certified pharmacist in the US with over 20 years of practice, compares Wegovy, Zepbound, Mounjaro, Ozempic and Trulicity.
Mounjaro - Pharmacist ExplainsIn this video, a pharmacist from the channel introduces Mounjaro, a newer medication that belongs to the same family as Ozempic.
Wegovy vs. Zepbound: The Slimming Drug ShowdownIn this 7:47 video, a clinical pharmacist who goes by the speaker compares Wegovy and Zepbound, two weekly injections approved for weight loss.
How to Switch from Ozempic (or Wegovy) to Mounjaro | Dr. Dan | Obesity ExpertThe speaker, who presents as an obesity expert and runs a pharmacy in Alberta, Canada, explains how he approaches switching from other GLP-1 medications to Mounjaro or Zepbound.
Read next
Our guides closest to what this video covers, with prices checked weekly.
- Mounjaro vs Ozempic, and the trial everyone quotes about it
Mounjaro is tirzepatide and Ozempic is semaglutide: different molecules, not two brands of the same drug. Both are approved for type 2 diabetes, and the weight-loss versions are Zepbound and Wegovy. In the one head-to-head trial, SURMOUNT-5, tirzepatide produced 20.2% mean body-weight loss at 72 weeks against semaglutide's 13.7%. The detail almost every page omits: that trial dosed semaglutide to 2.4 mg in people without diabetes, which is the Wegovy range. Ozempic tops out at 2 mg. The famous result did not test Ozempic's dose range.
- Mounjaro for weight loss, and why Zepbound exists
Mounjaro is tirzepatide approved for type 2 diabetes. Zepbound is the same molecule from the same maker, approved for weight management, and it goes to the same 15 mg. So unlike Ozempic and Wegovy, there is no dose ceiling pushing you from one to the other: the reason people move is coverage and cash price, not strength. Using Mounjaro for weight is off-label and a prescriber's decision. In the one head-to-head trial, tirzepatide beat semaglutide, 20.2% mean body-weight loss at 72 weeks against 13.7%.
- Semaglutide for weight loss: which version, and what each costs
Semaglutide is the molecule. For weight loss the FDA-approved version is Wegovy, sold as a weekly pen and a daily tablet. Ozempic is the same molecule approved for type 2 diabetes, so using it for weight is off-label. Compounded semaglutide uses semaglutide as its active ingredient, comes from a compounding pharmacy, is not FDA-approved, and is what most cash buyers actually take because it costs a fraction of the brand. All three produce the same side effects. What differs is the approval, the oversight and the price.
Next steps
Ozempic prices
Find more like it
Dose changeWeigh-in and resultsExercise and strengthHow it worksThe trials
Up next
More from this collection
Watched it? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.




















